IMV Corporation (7760) AI Stock Analysis

• Market Cap: ¥32.52B
• Dividend Yield: 1.45%
• Average Volume (3M): 105.65K
• Price to Earnings (P/E): 19.9
• Beta (1Y): 1.73
• Revenue Growth: 16.95%
• EPS Growth: 36.94%
• Country: JP
• Employees: 341
• Sector: Technology
• Sector Strength: 88
• Industry: Hardware, Equipment & Parts
• EPS (TTM): 34.90
• Shares Outstanding: 16,957,016
• 10 Day Avg. Volume: 129,880
• 30 Day Avg. Volume: 105,650
• PEG Ratio: 0.26
• Price to Book (P/B): 1.05
• Price to Sales (P/S): 0.70
• P/FCF Ratio: 11.15
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 66 Neutral
• Price Target: ¥2,002.00 ▼(-3.47% Downside)

IMV Corporation's strong financial performance, particularly in revenue growth and profitability, is a key strength. However, technical indicators suggest neutral momentum, and valuation metrics indicate fair pricing. The lack of recent earnings call data or notable corporate events limits additional insights.

IMV Corporation Business Overview & Revenue Model

Company Description

IMV Corporation manufactures and sells vibration simulation systems and measuring systems in Japan and internationally. It offers electrodynamic vibration test systems, measuring systems, vibration controllers, amplifier replacement, seismometers, vibration pick-up and sensors, and reliability evaluation systems. The company also develops, produces, repairs, and maintains vibration and environmental test systems. In addition, it offers test house, measuring analysis, and other consulting services for vibration tests. Further, the company leases vibration test machine. IMV Corporation was incorporated in 1957 and is headquartered in Osaka, Japan.

How the Company Makes Money

IMV Corporation generates revenue primarily through collaborations, grants, and research funding. Its revenue model includes partnerships with pharmaceutical companies for the development and commercialization of its product candidates, which may involve milestone payments and royalties upon successful commercialization. Additionally, IMV seeks funding through government grants and research initiatives that support its clinical trials and development programs. As a clinical-stage company, its revenue is largely dependent on achieving key development milestones and entering agreements that can provide financial backing while advancing its therapeutic offerings.

IMV Corporation Financial Statement Overview

Summary

IMV Corporation shows strong revenue growth and profitability, with a robust revenue growth rate and healthy profit margins. However, recent challenges in converting profits to operating cash flow indicate potential liquidity management issues.

Income Statement

IMV Corporation shows strong revenue growth and profitability. The TTM Gross Profit Margin stands at 37.21%, with a Net Profit Margin of 9.84%, indicating effective cost management. The company achieved a robust Revenue Growth Rate of 18.27% from 2023 to 2024, showing strong market demand. EBIT and EBITDA margins are healthy at 12.06% and 15.60%, respectively, demonstrating operational efficiency.

Balance Sheet

The company's financial position is stable with a Debt-to-Equity Ratio of 0.39, suggesting manageable leverage. The Return on Equity (ROE) is 15.36%, reflecting good profitability. The Equity Ratio of 49.52% indicates a balanced capital structure, though there is room to improve asset funding through equity.

Cash Flow

The cash flow analysis presents a mixed situation. While the Free Cash Flow growth was negative due to high capital expenditures, the Operating Cash Flow to Net Income Ratio is undefined due to zero operating cash flow in the TTM. Prior periods show strong cash generation relative to net income, but the recent data suggests a need for cash flow stabilization.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	17.42B	15.34B	13.73B	11.89B	11.58B	11.34B
Gross Profit	6.44B	5.78B	4.61B	3.96B	3.62B	2.93B
EBITDA	2.94B	2.45B	2.01B	1.95B	1.99B	1.02B
Net Income	1.59B	1.43B	1.13B	1.07B	937.26M	316.83M
Balance Sheet
Total Assets	21.50B	19.28B	17.29B	16.96B	17.12B	16.22B
Cash, Cash Equivalents and Short-Term Investments	3.93B	2.80B	2.18B	3.52B	3.88B	3.07B
Total Debt	3.72B	3.36B	3.26B	4.27B	5.21B	6.19B
Total Liabilities	10.18B	9.07B	8.04B	8.69B	9.59B	9.51B
Stockholders Equity	11.31B	10.22B	9.24B	8.28B	7.51B	6.70B
Cash Flow
Free Cash Flow	0.00	960.16M	-290.88M	324.96M	1.92B	-40.79M
Operating Cash Flow	0.00	2.01B	103.80M	742.24M	2.10B	500.38M
Investing Cash Flow	0.00	-1.03B	-329.37M	-189.17M	-162.83M	-545.48M
Financing Cash Flow	0.00	-360.87M	-1.18B	-1.00B	-1.16B	1.90B

IMV Corporation Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2074.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7760, the sentiment is Positive. The current price of 2074 is above the 20-day moving average (MA) of 1939.25, above the 50-day MA of 1876.34, and above the 200-day MA of 1642.07, indicating a bullish trend. The MACD of 48.33 indicates Negative momentum. The RSI at 59.82 is Neutral, neither overbought nor oversold. The STOCH value of 89.74 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7760.

IMV Corporation Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6266	79 Outperform	¥36.19B	9.48	―	1.41%	7.20%	-10.52%
7500	76 Outperform	¥38.86B	14.58	―	2.65%	6.32%	5.91%
6824	73 Outperform	¥54.13B	15.29	―	1.12%	9.96%	3.13%
7723	73 Outperform	¥44.64B	11.41	―	2.59%	7.99%	50.13%
6817	70 Outperform	¥37.20B	18.48	―	4.69%	-2.57%	3.43%
7760	66 Neutral	¥32.52B	19.90	―	1.45%	16.95%	36.94%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%